Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Teodor Duro
The Importance of Setting Treatment Goals for Cardiovascular Diseases
The Importance of Setting Treatment Goals for Cardiovascular Diseases () 1. Introduction Treatment guidelines are an important method of conveying expert opinion to non-expert physicians in complex diseases. Unfortunately, guidelines published by different medical specialties are often conflicting, thereby causing confusion to the practitioner. This conundrum has clearly been documented for the treatment of cardiovascular disease.
Optimal Prescribing of Statins to Reduce Cardiovascular Disease
Cardiovascular disease is the most common cause of death in the United States and worldwide. Most of this disease is preventable with improvement of lifestyle and medication to reduce circulating cholesterol. The most common medications prescribed to reduce cholesterol are statins, which inhibit the hepatic enzyme HMG CoA reductase, the limiting enzyme in cholesterol synthesis.
Improving Cardiovascular Risk Assessment to Optimize Therapy
1. Introduction Assessing the ten-year cardiovascular risk is an important function of all primary care physicians. Not only does this assessment provide a prognosis for the patient, but it also dictates the aggressiveness of the physician’s therapy. The traditional approach is to utilize one of the risk score calculators available on the internet (e.g., the American Heart Association risk calculator) [1].
Risk Assessment and Coronary Artery Calcium Scoring in Transgender and Gender-Diverse Individuals Receiving Gender-Affirming Hormone Therapy
Abstract Objective To evaluate cardiovascular risk factors and prevalent coronary artery disease (CAD) using Coronary Artery Calcium (CAC) scoring in transgender and gender-diverse (TGD) individuals receiving gender-affirming hormone therapy (GAHT) and compare the CAC scores of TGD individuals with those of the general population.
Barriers to Enrollment in Rheumatology Research: Who, What, Where, When, and Why?
Irrespective of ethnicity or site (FMC versus RUHS), we find that the concern for risks related to research is the leading barrier for patients enrolling in clinical research. However, the fear of discovering a serious illness was significantly greater in our Hispanic population compared to other ethnicities as well as patients seen at RUHS compared to FMC. On the other hand, work responsibilities ranked higher in NHW and patients seen in the university-based clinic.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Teodor
Contact Teodor, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack